trial
as of 2026-07-01V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
NCTId NCT00175513
at a glance
Phase 2 · Completed
Enrollment 100 (estimated)
Sponsored by University of British Columbia
Primary completion 2009-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 2
Status
Completed
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
None
Start
2005-09
Primary completion
2009-09
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of British ColumbiaLead Sponsor
Stanley Medical Research InstituteCollaborator
Investigators
1
William G Honer, ProfessorPrincipal Investigator
Sites
2 total
Victoria, CanadaWhite Rock, Canada
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
100
Phase
PHASE2
Primary Completion Date
2009-09
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator